Is Anavar Safe? What the Clinical Record Says

Is Anavar safe is a question with two honest answers that point in different directions, and both come from the same regulator. Oxandrolone was approved in the United States for 59 years, prescribed to children, burn patients, people with HIV wasting and the elderly, and in a 12-week trial at 20 mg a day in men aged 60 to 87 (Schroeder 2004) it did not impair liver function. In June 2023 the FDA withdrew approval of every oxandrolone tablet after telling the manufacturers that the potential problems with the drug were "sufficiently serious that the drug should be removed from the market", and in September 2023 it determined that the withdrawal was for reasons of safety or effectiveness. The drug did not change between those two facts; what changed was the regulator's view of the balance.

This page sets out what the trials measured, what the label warned about, which harms are dose-dependent and reversible, which are not, and who should not take it at all. The side effects guide lists every effect; this is the risk assessment.

The pattern across them is consistent. Lipids and liver enzymes move in every trial, in proportion to dose. Suppression of the body's own testosterone occurs even at 20 mg. Nothing in the trials reached the serious events on the label, which come from case reports over decades of androgen use, mostly at high doses for long periods. The trial that matters for the recreational user does not exist: no study has given healthy men 40 to 50 mg a day for six weeks and measured what happens, so the figures users quote for that dose, ALT and AST at two to three times baseline, HDL down 30 to 50%, are forum reports.

Liver enzymes, cholesterol and suppression are the three effects that track dose and length, and all three reverse after stopping in the evidence available. Twelve-week clinical courses at 20 mg did not impair liver function; the user pattern of a six-week course at 40 to 50 mg with enzymes returning to baseline over the following weeks is consistent with that but not proven by it. HDL recovers over weeks; the concern with repeated cycles is cumulative time spent with low HDL, which is a cardiovascular risk factor, not a transient inconvenience. Suppression recovers on its own after short courses or with PCT after longer ones; the PCT guide covers when each applies.

Three harms do not fit the "stop and it recovers" pattern. Virilisation in women, voice deepening and clitoral enlargement, can be permanent once established, which is why Anavar for women is built around stop rules rather than doses. Hair loss in men with the genetics for it is a DHT-derivative effect that finasteride does not block, covered in Anavar and hair loss. And the label's serious hepatic events, peliosis hepatis and liver tumours, are rare, associated with prolonged use, and are the reason the label and every clinical regimen limited courses to weeks. These are the warnings the FDA cited in 2023.

The label's contraindications are specific: known or suspected prostate cancer or male breast cancer, breast cancer in women with high calcium, pregnancy, nephrosis, and hypercalcaemia. The practical additions from the trial data: anyone with liver disease or already-raised enzymes, anyone with low HDL or a cardiovascular history, and adolescents, in whom androgens close the growth plates. A man already on TRT has one fewer problem, suppression, and the same lipid and liver ones, set out in Anavar and TRT.

Within the oral steroids the comparison holds: oxandrolone raises liver enzymes less than stanozolol, far less than oxymetholone, does not aromatise like methandienone and has the lowest androgenic signal of the group, the reasons it is called the mildest oral. The comparisons are in Anavar vs Winstrol, vs Anadrol and vs Dianabol. "Safest steroid" is a ranking within a class that the regulator has now judged, for this compound, not safe enough to keep on the market at any approved dose. Both statements are true, and a decision to use it should be made knowing both.

This article is for educational and harm-reduction purposes only and is not medical advice. Oxandrolone is a prescription-only or controlled substance in most countries; anyone considering it should consult a licensed physician.

Anavar.org is an independent educational resource. We are not affiliated with any pharmaceutical manufacturer or healthcare provider. This content is for informational purposes only and does not constitute medical advice. Images on this site are illustrative artwork made for editorial purposes; they do not show real products, packaging or labels and are not an advertisement or an offer to sell.